Despite the current undervaluation of PTVE, the negative growth outlook introduces a level of uncertainty and risk. Potential investors are advised to research further into the stock and consider the risks associated with negative future growth prospects.
The pessimism of the analyst cohort reflected in Pactiv Evergreen's declining revenue forecasts might impact its stocks. The current high P/S may not be sustainable due to these decreasing revenues.
Although Pactiv Evergreen's dividends were covered by free cash flow, its lack of profitability last year is worrisome. Dividend investors need to see evidence of sustained profitability to be positive.
パクティブ・エバーグリーンに関するコメント
• $ヴィクトリアズ・シークレット (VSCO.US)$ +10.4% (In reaction to earnings)
• $セールスフォース (CRM.US)$ +9.0% (In reaction to earnings)
• $ナビゲーター・ホールディングス (NVGS.US)$ +4.9% (names Mads Peter Zacho as CEO)
• $ウェイボー (WB.US)$ +4.7% (In reaction to earnings)
• $CAE・インク (CAE.US)$ +4.7% (In reaction to earnings)
• $バイタル・エナジー (LPI.US)$ +4% (authorized $200 mln share repurchase program)
• $アクサム・セラピューティクス (AXSM.US)$ +3.1% (Late-Breaking Presentations of P...
• $ジェンコ・シッピング&トレーディング (GNK.US)$ +4.7% (positive Barrons article)
• $ネクストディケイド (NEXT.US)$ +4.7% (files for 4618226 share common stock offering by selling shareholder)
• $コンパス・パスウェイズ (CMPS.US)$ +4.7% (COMPASS Pathways presents largest ever study of psilocybin therapy at American Psychiatric Association annual meeting)
• $カヌー (GOEV.US)$ +3.5% (files for 48043111 share common stock offering by selling shareholder)
• $アメリカン・アクスル・アンド・マニュファクチャリング (AXL.US)$ +3.7% (pr...
• $キューブスマート (CUBE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $52 (from $60)
• $ディーティーイー・エナジー・カンパニー (DTE.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $140 (from $142)
• $コンソリデーテッド・エジソン (ED.US)$ : Guggenheim Upgrades to Neutral from Sell - PT $94 (from $80)
• $モトローラ・ソリューションズ (MSI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $240
• $グルポ・エアロポルチュアリオ・デル・セントロ・ノルテ ADR (OMAB.US)$ : Morgan Stanley Upgrades to...
• $ブート・バーン・ホールディングス (BOOT.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $121 (from $109)
• $イーピーエーエム・システムズ (EPAM.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $400 (from $312)
• $ハーシャ・ホスピタリティー・トラスト (HT.US)$ : Stifel Upgrades to Buy from Hold - PT $14.50 (from $11)
• $ジョンス・セラピューティクス (JNCE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $20 (from $15)
• $パクティブ・エバーグリーン (PTVE.US)$ : RBC Capital Upgra...
• $CDWコープ (CDW.US)$: Stifel Upgrades to Buy from Hold - PT $210 (from $200)
• $コルテバ (CTVA.US)$ : Loop Capital Upgrades to Buy from Hold - PT $69
• $コアシビック (CXW.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $10.85)
• $デルタ航空 (DAL.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $60 (from $42)
• $エイチ・ビー・フラー (FUL.US)$ : Baird Upgrades to Outperform from Neutral - PT $85
• $ハンティントン・インガルス・インダストリーズ (HII.US)$ : Cowen U...
the float still so much left?
まだコメントはありません